The filing is a routine RSU-cover-to-tax sale by an officer with no discretionary signal. Monitor for any subsequent Form 4 filings to confirm execution, but no trading action is warranted based on this notice alone.
Price Chart
Executive Summary
Erick Lucera, an officer of Dyne Therapeutics, filed a Form 144 on August 13, 2026, indicating intent to sell 1,797 shares of common stock with an approximate market value of $47,226. The shares were acquired via restricted stock unit vesting on August 12, 2026, and the sale is for equity compensation-related tax obligations. Given the small size relative to the company's $4.9B market cap and the routine nature of RSU-based sales, this filing is neutral.
Key Facts
- Officer Erick Lucera filed Form 144 to sell 1,797 shares of Dyne Therapeutics common stock.
- Estimated sale value is approximately $47,226 based on filing date.
- Shares were acquired via restricted stock unit vesting on August 12, 2026.
- Sale is for equity compensation-related purposes, not a discretionary open-market exit.
- The proposed sale represents a negligible fraction of the company's $4.9B market capitalization.
Financial Impact
Proposed sale of 1,797 shares worth ~$47,226, immaterial relative to $4.9B market cap.
Risk Factors
- Form 144 is an intent to sell — the sale may not be executed.
- No material risk to the company or stock from this de minimis insider sale.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001972481-26-000259 |
| Document: 0001972481-26-000259-index.html | 0001972481-26-000259 |
| Document: 0001972481-26-000259.txt | 0001972481-26-000259 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Insider Cluster | $26.15 $17.90 | ▲ +31.55% | ▲ +29.57% | $15.20 (+41.87%) |
Aug 14, 2026 6w ago | 144 | $26.15 $18.52 | ▼ −29.18% | ▼ −27.65% | $15.20 (−41.87%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▲ +27.94% | ▲ +25.95% | $15.20 (+40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Aug 13, 2026 7w ago | 144 | $25.70 $18.52 | ▼ −27.94% | ▼ −25.95% | $15.20 (−40.86%) |
Jul 29, 2026 9w ago | Press Release | $25.73 $26.09 | ▲ +1.40% | ▼ −2.57% | $15.20 (−40.92%) |
Jul 22, 2026 10w ago | Press Release | $23.21 $26.78 | ▼ −15.38% | ▼ −12.48% | $15.20 (+34.51%) |
Jul 20, 2026 10w ago | 8-K | $23.45 $26.15 | ▲ +11.51% | ▲ +7.39% | $15.20 (−35.18%) |
Jun 30, 2026 13w ago | Insider Cluster | $21.79 $25.10 | ▲ +15.19% | ▲ +17.38% | $15.20 (−30.24%) |
Jun 29, 2026 13w ago | 144 | $22.21 $25.63 | ▼ −15.40% | ▼ −16.43% | $15.20 (+31.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access